drugset / Trial / NCT00106821

Efficacy of Tiotropium in Patients of African Descent With Chronic Obstructive Pulmonary Disease

NCT00106821

Phase 4 Completed 166 enrolled Boehringer Ingelheim
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to look at the benefits of tiotropium, an approved drug for the treatment of bronchospasm associated with COPD (chronic obstructive pulmonary disease), in a population of patients with COPD who are of African American descent.

Timeline

Start
2004-06
Primary completion
2005-08
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject Tiotropium Other / unclassified Inhaled